CVE:LTYLiberty Biopharma Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Liberty Biopharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume700 shsAverage Volume23,286 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesSocial Media Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Liberty Biopharma. Previous Next 2.9 Community Rank Outperform VotesLiberty Biopharma has received 83 “outperform” votes. (Add your “outperform” vote.)Underperform VotesLiberty Biopharma has received 62 “underperform” votes. (Add your “underperform” vote.)Community SentimentLiberty Biopharma has received 57.24% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Liberty Biopharma and other stocks. Vote “Outperform” if you believe LTY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LTY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldLiberty Biopharma does not currently pay a dividend.Dividend GrowthLiberty Biopharma does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Liberty Biopharma insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Liberty Biopharma is -12.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Liberty Biopharma is -12.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.58 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:LTY Previous SymbolCVE:VVA CUSIPN/A CIKN/A Webwww.libertybiopharma.com Phone+1-604-3777575Debt Debt-to-Equity Ratio8.19 Current Ratio0.12 Quick Ratio0.12Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash Flow2,000.00 Book ValueC$0.79 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:LTY Rates by TradingView Receive LTY News and Ratings via Email Sign-up to receive the latest news and ratings for LTY and its competitors with MarketBeat's FREE daily newsletter. Liberty Biopharma (CVE:LTY) Frequently Asked Questions Has Liberty Biopharma been receiving favorable news coverage? Media coverage about LTY stock has been trending very positive this week, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Liberty Biopharma earned a news sentiment score of 4.0 on InfoTrie's scale. They also gave news headlines about the biotechnology company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an effect on the stock's share price in the near term. View the latest news aboutLiberty Biopharma. Who are some of Liberty Biopharma's key competitors? Some companies that are related to Liberty Biopharma include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Admedus (AHZ), AIkido Pharma (SONN), Almirall (LBTSF), Amarantus Bioscience (AMBS), Antibe Therapeutics (VBIZF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE) and Canada House Wellness Group (CHV). View all competitors. What other stocks do shareholders of Liberty Biopharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Liberty Biopharma investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), ARBOR RLTY TR I/SH (ABR), Advanced Emissions Solutions (ADES), Archer Daniels Midland (ADM), AGNC Investment (AGNC), Aphria (APHA), Apple Hospitality REIT (APLE) and Apollo Global Management (APO). Who are Liberty Biopharma's key executives? Liberty Biopharma's management team includes the following people: Mr. Norman Tsui, Pres, CEO & Director (Age 45)Mr. Shui Yan Tam, Chief Financial Officer (Age 44)Dr. Michael T. McNamara, Medical Advisor & DirectorDr. Richard Huang Ph.D., Chief Technology Officer (Age 42)Dr. Richard Cook M.D., Msc., FRCSC, Chief Medical Officer What is Liberty Biopharma's stock symbol? Liberty Biopharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LTY." How do I buy shares of Liberty Biopharma? Shares of LTY and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Liberty Biopharma's official website? The official website for Liberty Biopharma is www.libertybiopharma.com. How can I contact Liberty Biopharma? Liberty Biopharma's mailing address is 2270-8788 McKim Way, RICHMOND, BC V6X 4E2, Canada. The biotechnology company can be reached via phone at +1-604-3777575. This page was last updated on 6/5/2020 by MarketBeat.com Staff
